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A conscience vote of individual parliamentarians in the Australian government last 
month regarding amendments to current legislation regulating human embryonic stem 
cell research yielded a surprising outcome. Despite opposition by the Australian Prime 
Minister, the Senate and House of Representatives voted to adopt the recommendations 
of the Lockhart Review and approve human somatic cell nuclear transfer, thus providing a 
consistent national policy for all researchers in Australia.Australia has an outstanding record 
in reproductive biology research and 
clinical translation commencing with 
the first child born by in vitro fertiliza-
tion (IVF) in 1980 (2 years after Step-
toe’s and Edward’s original IVF suc-
cess in the UK) and the first live birth 
from a frozen IVF embryo in 1983 (Lee-
ton, 2004). Today, approximately 2% of 
births in Australia involve some form of 
assisted reproductive technology.
The techniques that are essential 
for assisted reproductive technol-
ogy, including human egg collec-
tion and the creation and freezing of 
embryos, are also the core method-
ologies by which human embryonic 
stem cells are isolated. The Austral-
ian government’s commitment to 
human embryonic stem cell research 
seemed assured in 2002 with the 
award of $98.5 million in federal 
grants to establish the Australian 
Stem Cell Centre in Melbourne. The 
center conducts research on both 
embryonic and adult stem cells, tis-
sue repair, and immune modulation. 
Simultaneously, the Australian parlia-
ment began debating legislation to 
regulate the use of human embryos 
in research. Legislation was enacted 
that allowed the granting of licenses to 
use surplus IVF embryos for research 
but banned somatic cell nuclear 
transfer (SCNT) (Wilmut et al., 1997), 
a technique that can be used to gen-erate patient-specific human embry-
onic stem cell lines for the study of 
different diseases. Since 2002, only 
nine licenses for experimentation 
involving human embryos have been 
issued: five for further development 
of assisted reproductive technologies 
and four for derivation of new human 
embryonic stem cell lines.
As part of this legislation, the Aus-
tralian government commissioned an 
independent committee chaired by 
former federal judge John Lockhart 
to review the effects of these regula-
tions on assisted reproduction and 
on research efforts and their pos-
sible therapeutic applications. After 
reviewing over 1000 submissions 
and international practices and after 
extensive discussions with state gov-
ernments, other stakeholders, and 
the community, the Lockhart Review 
committee produced 54 recommen-
dations for the government to con-
sider and proposed amending cur-
rent legislation to allow SCNT under 
license and following strict guidelines 
(Australian Government, 2005).
A key observation of the Lockhart 
Review was that there is no single 
societal view on research using human 
embryos. Rather, such research 
encompasses many questions of 
fundamental scientific, religious, and 
moral importance. There are many 
strongly held, and often entrenched Cell 128, Japositions, and the reality is that very 
few of the opponents or proponents 
would be expected to change their 
minds. Because of these divergent 
views, the committee accepted that 
some disagreement would remain, 
whether or not any changes were 
made to the existing legislation. 
However, the committee also noted 
broad community support for medical 
research and for clinically assisting 
people to have children, even though 
this process involves the “wastage” of 
some embryos. The Lockhart Review 
argued that even though some peo-
ple think that an activity is unethical, 
it does not follow that such an activ-
ity should be illegal. The committee 
considered that the wider the range of 
ethical views on a particular activity, 
the weaker the case for declaring that 
activity illegal. SCNT was highlighted 
as the Rubicon over which public opin-
ion was divided. The Lockhart Review 
recognized that apart from outright 
support or outright opposition, there 
were three major arguments concern-
ing SCNT that the government needed 
to consider.
“It is wrong to create human 
embryos with the sole purpose of 
destroying them for the derivation 
of stem cells.”
The committee agreed that human 
embryonic clones created by SCNT 
are human embryos with the capabil-
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ity, under certain (prohibited) condi-
tions, of developing into humans. 
However, the committee stated that 
the question of intent was important. 
Under these circumstances there was 
no intent to create a human but rather 
a collection of cells that are identi-
cal to, and therefore an extension 
of, the tissues of the donor. Further, 
the committee took the view that the 
moral significance of cloned embryos 
that are not implanted is more linked 
to their potential for research into 
treatments for serious diseases and 
not their potential as human lives. The 
committee recognized that this view 
is supported by many people but is 
also unacceptable to many others.
“Community support for medical 
research and acceptance of pro-
cesses aimed at assisting people 
to have children.”
The current use and wide acceptance 
of assisted reproductive technologies 
means that excess human embryos 
are currently created knowing that 
those not used for procreation are 
destined for destruction. A number of 
Australian states require the destruc-
tion of surplus IVF embryos after 5 or 
10 years. These embryos are allowed, 
under current strict legal guidelines, 
to be used for both IVF and stem cell 
research. The committee regarded as 
inconsistent the position of accept-
ing one destructive use and denying 
another, particularly when both uses 
aim to alleviate medical conditions, 
either infertility or a range of serious 
diseases.
“The slippery slope.”
Although SCNT may be intended 
for good, for example, to produce 
patient-specific human embryonic 
stem cell lines for studying differ-
ent diseases (therapeutic cloning), 
it could also be used for unethical 
purposes, for example, to produce 
live born humans from embryos gen-
erated by SCNT (reproductive clon-
ing). One argument put forward to 
the committee was that allowing the 
former will inevitably lead to the latter. 
However, the Lockhart Review com-
mittee had already recommended 
that human reproductive cloning 
should continue to be prohibited on 
the grounds of both ethics and safety, 
•
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was rejected. The committee did note 
that when considering currently pro-
hibited practices involving embryos 
(including embryos created by SCNT 
or other methods not involving fertil-
ization of eggs by sperm or embryos 
with genetic material from more than 
two people) the strongest community 
objection was to the implantation of 
such embryos into a woman’s body 
or to their development beyond 14 
days. Thus, the committee recom-
mended that a number of currently 
prohibited practices involving human 
embryos should be permitted under 
strict legal guidelines providing that 
such embryos do not develop beyond 
14 days and are not implanted into a 
woman’s or animal’s body.
In recommending that SCNT be 
permitted under license, the Lock-
hart Review did emphasize concerns 
about the difficult issues surround-
ing human egg donation and the 
possibility of donor coercion, a situ-
ation that arose during the research 
of Woo-Suk Hwang in South Korea 
(Magnus and Cho, 2005; Stein-
brook, 2006). So strict guidelines 
were proposed to protect against 
such abuse. The Lockhart Review 
also reported several unexpected 
findings, such as that current legis-
lation adversely impacted the prac-
tice of reproductive medicine (by 
restricting training of technicians for 
assisted reproductive technologies, 
and by effectively banning sperm 
competency tests that use mam-
malian eggs). A second unexpected 
issue was the lack of requests from 
researchers for creating human 
embryos for research by the union 
of sperm and egg, which is currently 
permitted in the UK under strict 
guidelines but not in Australia.
After considering the Lockhart 
Review, the Australian Prime Minis-
ter, John Howard, opposed adopt-
ing the committee’s recommenda-
tions (Howard, 2006). Within the 
Australian government, the split 
opinions of politicians seemed to 
reflect a similar split among the 
general public (Murphy, 2006). Fol-
lowing considerable public debate, 
and equivalent debate by the cabi-evier Inc.net and party room of the Govern-
ment, the Prime Minister announced 
the highly unusual step of allowing 
all parliamentarians to take a con-
science vote on any bill pertaining 
to adoption of amended legislation. 
Senator Kay Patterson, a former 
Health Minister, sponsored a Private 
Members Bill that sought to imple-
ment the reforms recommended by 
the Lockhart Review. In November 
of last year, the Senate narrowly 
voted in favor of the Bill, 34 votes 
to 32, although a key amendment 
was accepted in which SCNT using 
animal eggs would be prohibited. 
Last month, the Bill was presented 
to the House of Representatives, 
who voted 82 to 62 to accept the 
amended Bill.
Australia now has legislation, 
regulating research involving human 
embryos and SCNT, that is nation-
ally more consistent and embracing 
than that in the US, where there are 
differing rules for private companies 
versus government-funded research 
and substantial differences between 
different states in the ability to con-
duct such work. In September of last 
year, President Bush vetoed a Bill 
passed by the US Senate that sought 
to loosen restrictions on federal 
funding for human embryonic stem 
cell research, indicating that current 
restrictions are likely to continue in 
the US (Bush, 2006).
Consistent with the British lead 
in liberal regulation of this research 
field, SCNT using donated human 
eggs will now be allowed in Australia 
(the new amendments take effect 
in June this year). By introducing 
a licensing system for research-
ers wishing to perform SCNT, Aus-
tralia joins countries such as the 
UK, Belgium, and China. Grant-
ing licenses for research involving 
SCNT is seen as an option with 
greater built-in safeguards than, for 
example, allowing SCNT by not spe-
cifically prohibiting it (as is the case 
in South Korea). Consistent with 
community attitudes, the produc-
tion of embryos by egg and sperm 
for research will not be permitted in 
Australia, although other countries 
such as the UK, Belgium, China, 
Singapore, South Korea, and Swe-
den permit this.
By establishing clear and strict 
guidelines to permit the conduct of 
research involving human embryos in 
Australia, the incentive for research-
ers to move to other countries with 
less regulated ethical approaches is 
reduced. By adopting the recommen-
dations of the Lockhart Review, Aus-
tralia joins a cluster of other countries 
in providing a consistent national 
blueprint for responsible research 
involving human embryos.ACknowlEdgmEntS
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